Drug Type Small molecule drug |
Synonyms BXL-628, RO-26-9228, RO269228 |
Target |
Action agonists |
Mechanism VDR agonists(Vitamin D receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC29H43FO2 |
InChIKeyLRLWXBHFPGSUOX-GJQYOBCGSA-N |
CAS Registry199798-84-0 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Urinary Bladder, Overactive | Phase 2 | Italy | 10 Apr 2008 | |
Urinary Bladder, Overactive | Phase 2 | Netherlands | 10 Apr 2008 | |
Urinary Bladder, Overactive | Phase 2 | United Kingdom | 10 Apr 2008 | |
Infertility, Male | Phase 2 | Italy | 10 Oct 2007 | |
Prostatic Hyperplasia | Phase 2 | Germany | 28 Aug 2006 | |
Prostatic Hyperplasia | Phase 2 | Italy | 28 Aug 2006 | |
Prostatitis | Phase 2 | Italy | 07 Nov 2005 | |
Osteoporosis, Postmenopausal | Clinical | United States | - | - |
Osteogenesis Imperfecta | Preclinical | United States | - | |
Rett Syndrome | Preclinical | United States | - |